Banner
Late-Breaking Analysis In Hypertension Shows That Antihypertensive Treatments Differ In Their Ability To Preserve Lives

STOCKHOLM, August 30, 2010 /PRNewswire/ -- According to the results of a late-breaking analysis...

Clinical Results For New Treatment Of Bacterial Vaginosis Infection

The Swedish company Laccure AB recently got CE marking as a Class IIa medical device product for...

88 Percent Of UK Doctors Believe Whiplash Claims Are Exaggerated

AXA, a UK car insurer, has surveyed UK doctors as part of its ongoing campaign to understand the...

On Facebook, Women Are More Plentiful But Men Are Better Ad Targets

Global digital marketing companies Resolution Media and Kenshoo Social published a new report today...

User picture.
Anna OhldenRSS Feed of this column.

Media Relations Executive, PR Newswire Europe... Read More »

Blogroll

CAPE TOWN, South Africa, March 4 /PRNewswire/ -- New data released at the World Congress of Anaesthesiologists (WCA) show that IONSYSTM (fentanyl iontophoretic transdermal system - ITS) may save hospital staff time compared to Intravenous Patient Controlled Analgesia (IV PCA).

Fentanyl ITS, a new innovative, needle-free system indicated for the management of acute postoperative pain in a hospital setting, was launched in European countries starting in January this year. Fentanyl ITS has been shown to be as effective as IV PCA morphine for the management of acute postoperative pain.(1)

REDMOND, Washington, March 4 /PRNewswire/ --

- Customers get immediate access to the new service that extends Microsoft Office, provides anywhere access to documents and enables sharing functionality.

Microsoft Corp today announced the public availability of Microsoft Office Live Workspace beta (http://workspace.officelive.com), the new web-based extension of Microsoft Office that lets people access their documents online and share their work with others. Office Live Workspace was among the first entries in the new wave of online services in Microsoft's software plus services vision previewed last fall.

(Logo: http://www.newscom.com/cgi-bin/prnh/20000822/MSFTLOGO)

SAN RAMON, California, March 3 /PRNewswire/ --

Prodiance Corporation, the leading provider of enterprise spreadsheet management solutions, today announced that it will host an online seminar with Microsoft and Ventana Research for senior executives entitled: "21st Century Spreadsheets: Business Value Driver or Clear &: Present Risk?".

The seminar will last approximately 60 minutes, and will be held on Wednesday, March 12th, 2008 at 1:00 pm EDT. It will feature industry experts from Microsoft's Financial Services industry group along with leading industry analysts to discuss the key issues every organization faces in managing mission critical spreadsheets.

SAN DIEGO, March 3 /PRNewswire/ --

LUGANO, Switzerland, March 3 /PRNewswire/ -- Helsinn Healthcare SA, a Swiss pharmaceutical group, together with its partner Eisai Corporation of North America and Eisai's U.S. subsidiary, MGI Pharma, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Aloxi(R) (palonosetron hydrochloride) injection for the prevention of postoperative nausea and vomiting (PONV) for up to 24 hours following surgery. Efficacy beyond 24 hours has not been demonstrated.

WILTON, Connecticut, March 3 /PRNewswire/ --

Startech Environmental Corp. (OTC Bulletin Board: STHK), a fully reporting company and the internationally recognized, Award-winning environment and energy company announced today that its 2007 Year End Report, filed on schedule with the SEC, shows Shareholders' Equity in excess of US$4.4 million with approximately US$11.6 million in Cash on Hand, along with Plasma Converter Sales Bookings of approximately US$25 million.

The Company also announced the Annual Shareholders Meeting in May in its recent filing with the SEC.